This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues.Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited.
IntroductionThere is compelling evidence suggesting that magnesium depletion may play a role in the pathophysiology of insulinresistance and/or altered glucose homeostasis in type 2 diabetes mellitus [1][2][3]. Magnesium is the second most abundant intracellular cation after potassium, and it is involved in a number of fundamental biochemical processes, comprising all ATP transferAbbreviations: ATP, adenosine triphosphate; BMI, body mass index; DBP, diastolic blood pressure; ESRD, end stage renal disease; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; ISE, ion-selective electrode; NADPH, nicotinamide adenine dinucleotide phosphate-oxidase; NMR, nuclear magnetic resonance; Mg-tot, total serum magnesium; Mg-ion, extracellular free levels of magnesium; SBP, systolic blood pressure. ☆ None of the authors has any conflict of interest or financial support to disclose. ☆☆ There was no external funding for the study.
Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources. For an appropriate treatment of heart failure with preserved ejection fraction (HFpEF), there are no specific drugs effective for this condition. Those indicated in HF with reduced EF (HFrEF) are of more benefit in that form of HF, according to the guidelines of the European Society of Cardiology of 2016: ACE-inhibitors, beta-blockers, anti-aldosterones are all indicated with a class of recommendation/level of evidence IA; therapy with loop diuretics is indicated in the case of clinical congestion (IB). Studies carried out with ACE-inhibitor (or angiotensin-receptor antagonist) or beta-blocker or anti-aldosterone to evaluate their efficacy also in HFpEF have substantially shown a benefit only on a reduction in the hospitalization rate. The same guidelines identify regular aerobic activity (IA) as more effective in the condition of HFpEF and indicate, appropriately, the need to treat comorbidities (IC) in the elderly (where they are more present and more numerous). They also recommend to avoid certain associations of drugs and, obviously, harmful (and contraindicated) medications that could worsen the clinical picture or might be potentially lethal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.